| Financial Year |
March 31 2023 |
| Monetary Funds |
2,355,381,825.75 |
| Held-for-trading Financial Assets |
373,849.74 |
| Notes Receivable |
929,186,413.25 |
| Accounts Receivable |
2,005,886,783.68 |
| Advances to Suppliers |
500,584,167.35 |
| Other Receivables |
402,165,486.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,093,906,196.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
129,906,146.45 |
| Total Current Assets |
7,973,408,806.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
174,780,503.52 |
| Investment Properties |
59,553,251.52 |
| Fixed Assetes |
3,854,562,151.64 |
| Under-construction Projects |
1,104,936,701.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,023,099,284.46 |
| R&D expenses |
57,239,376.08 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,760,201.67 |
| Deferred Income Tax Assets |
59,670,813.93 |
| Other Non-Current Assets |
537,010,172.67 |
| Sub-Total of Non-Current Assets |
6,915,212,945.77 |
| Total Assets |
14,888,621,752.74 |
| Short-Term Loans |
622,154,611.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
318,990,749.17 |
| Accounts Payable |
1,170,763,345.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
216,661,693.60 |
| Taxes Payable |
158,968,647.06 |
| Interest Payable |
-- |
| Dividend Payable |
1,000,000.00 |
| Other payables |
324,831,805.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,644,577.02 |
| Other Current Liabilities |
538,955,279.31 |
| Sub-Total of Current Liabilities |
4,023,904,778.73 |
| Long-term Loans |
1,427,668,421.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,031,061.24 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
66,466,945.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,396,153,283.78 |
| Total Liabilities |
6,420,058,062.51 |
| Paid-In Capital(Or Share Stock) |
911,473,807.00 |
| Capital Surplus |
2,561,293,321.00 |
| Surplus Reserve |
281,391,166.87 |
| LESS:Treasury Stock |
79,705,923.61 |
| Undistributed Profits |
4,682,951,059.71 |
| Minority Stockholder's Interest |
22,748,394.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,445,815,295.75 |
| Owner's Equity（Stockholder's Equity） |
8,468,563,690.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,888,621,752.74 |
